L26/P-007 Mitochondrial and germ-cell cfDNA signatures in seminal plasma track testicular spermatogenic activity in azoospermic men
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Lazovska und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does seminal plasma cfDNA contain molecular signatures that are associated with testicular spermatogenic activity and clinically relevant heterogeneity in azoospermic men? Summary answer Seminal cfDNA contains mitochondrial and nuclear testis-derived signals that define a continuous molecular gradient associated with spermatogenic activity and TESE outcome. What is known already Seminal plasma contains cell-free DNA (cfDNA) originating from the male reproductive tract. Fragment size and concentration have been associated with semen quality, but the biological sources of cfDNA heterogeneity remain poorly understood. Tissue-of-origin approaches suggest contributions from testicular cells, yet it is unclear which cfDNA features dominate inter-individual variation or whether these reflect spermatogenic activity. In azoospermia, no reliable non-invasive biomarker exists to distinguish residual sperm production from complete testicular failure, resulting in frequent diagnostic testicular biopsies. Study design, size, duration Retrospective exploratory study of seminal plasma cfDNA from men with normozoospermia (n = 9), cryptozoospermia (n = 7), oligozoospermia (n = 8), obstructive (n = 2) and non-obstructive azoospermia (n = 9), including patients with known TESE outcome (n = 5). Multivariate analysis was applied to cfDNA-derived pseudotranscriptomic profiles. Participants/materials, setting, methods cfDNA was isolated from seminal plasma and sequenced using low-coverage paired-end short-fragment-optimised libraries. Gene-level cfDNA profiles were generated by Fourier transform–based pseudotranscriptomic analysis and analysed by principal component analysis (PCA). Mitochondrial DNA (chrM) coverage was quantified from sequencing and validated by digital PCR. Nuclear cfDNA tissue-of-origin was assessed by correlation to Human Protein Atlas transcriptomes with mitochondrial genes excluded. Main results and the role of chance PCA of cfDNA pseudotranscriptomes revealed a dominant gradient (PC1) explaining 79.8% of total variance. PC1 was strongly associated with normalized chrM coverage (R² = 0.53), indicating that mitochondrial cfDNA abundance was a major contributor to inter-sample variation. Digital PCR confirmed large differences in mitochondrial copy number between samples, which correlated with sequencing-derived chrM estimates (Spearman ρ = 0.74, p < 0.0001, n = 22). Samples were distributed continuously along this mitochondrial gradient, with Sertoli-cell-only and TESE-negative azoospermic patients located toward the high-chrM end, and normozoospermic, cryptozoospermic, oligozoospermic and TESE-positive samples toward the low-chrM end.Using nuclear cfDNA pseudotranscriptomes with mitochondrial genes excluded, samples showed the highest similarity to testis compared with all other tissues in the Human Protein Atlas reference. This nuclear testis similarity score was associated with the low-mitochondrial end of PC1 (R² = 0.13), consistent with increasing germ-cell contribution along the same molecular gradient. Together, mitochondrial and nuclear germ-cell cfDNA signals form a biologically coherent continuum that tracks testicular spermatogenic activity and aligns with TESE outcome. Limitations, reasons for caution TESE outcome was available for a limited subset of azoospermic patients, and sequencing depth was low. Findings should be considered exploratory and require validation in larger, prospectively phenotyped cohorts. Wider implications of the findings Seminal plasma cfDNA provides a quantitative, non-invasive molecular readout associated with testicular spermatogenic activity. Combining mitochondrial DNA abundance with nuclear testis-derived cfDNA signatures offers a mechanistically grounded framework for stratifying azoospermia and guiding TESE prioritisation. Trial registration number No
Zitieren
APA
Lazovska, M., Gudra, D., Gailite, L., & Erenpreiss, J. (2026). L26/P-007 Mitochondrial and germ-cell cfDNA signatures in seminal plasma track testicular spermatogenic activity in azoospermic men. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.343
Vancouver
Lazovska M, Gudra D, Gailite L, Erenpreiss J. L26/P-007 Mitochondrial and germ-cell cfDNA signatures in seminal plasma track testicular spermatogenic activity in azoospermic men. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.343
BibTeX
@article{Lazovska2026,
author = {Lazovska, M. and Gudra, D. and Gailite, L. and Erenpreiss, J.},
title = {L26/P-007 Mitochondrial and germ-cell cfDNA signatures in seminal plasma track testicular spermatogenic activity in azoospermic men},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.343}
}
EUVIMED